Key Insights

Highlights

Treatment Research

1 treatments under study, led by Nitric Oxide

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Research Network

Common Treatments

  • Nitric Oxide1

Active Sponsors

  • University of Florida1
  • Mallinckrodt1

Top Investigators

Related Conditions

  • Persistent Pulmonary Hypertension Of Newborn1
  • Persistent Fetal Circulation Syndrome1

Activity Timeline